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Dose-effect relations of mariiuana smoking on various 
physiological parameters in experienced male users 
Observations on limits of self-titration of intake 
The effects of smoking three different grades of marijuana (0, 0.5, and 2.9% A9 
tetrahydrocannabinol [THC]) were determined on various physiological subjective end 
pOints in experienced users tested blind at intervals of at least one week. The largest amount 
of AY THC equivalent taken by self-titration was 31 mg. After 2.9% AY THC marijuana, clear 
thinking was significantly reduced, dizziness increased, palpebral fissures narrowed, and 
pupils slightly decreased. There was dose-related increase in the amplitude of the patellar 
reflex and heart rate, significant at both dose levels. The 2.9% AY THC-containing marijuana 
also slightly elevated systolic and diastolic blood pressure. Pulse rate changes were found to 
be correlated with subjective estimates of the marijuana "high." Of the 18 subjects smoking 
the strongest material, 2 had panic reactions and 3 visual distortions and hallucinations. One 
subject became semicomatose. The majonty of subjects found their experience satisfying and 
reinforcing. One extremely heavy marijuana user tendea to show less effects than one less 
experienced user taking the same dose. 
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There is now an extensive literature on 
the pharmacological and behavioral effects 
of marijuana smoking in man.15, 19, 20, 24 In 
spite of this it is surprising that there is 
relatively little information on dose-effect 
in man.12, 13, 16, 17 This study was initiated 
in part to provide more basic information 
on the dose-effect relationships of smoking 
marijuana of different THe content on 
various physiological end points: subjective 
estimates of the marijuana "high," subjec-
tive measures of mood, pupil size, palpebral 
fissure size, patellar reflex, systolic and dia-
stolic blood pressure, and heart rate. This 
study was done as an introduction to other 
psychopharmacological investigations.21 ,22 
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Methods 
The subjects were 30 adult male ex-
perienced volunteer users of marijuana. 
Volume 15 
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The approximate number of times each 
had used marijuana in the preceding year 
varied widely, ranging from several to as 
many as once or twice daily. All were 
young adults, from 21 to 33 years old. Most 
were university students. Subjects were 
selected on the basis that they were physi-
cally healthy and mentally normal with the 
exception of drug experimentation. Most 
were habitual users of marijuana and gen-
erally did not take other drugs. Obvious 
exceptions were coffee drinking, tobacco 
smoking, and occasional alcohol. In addi-
tion to medical and psychiatric examina-
tions, all subjects were given the MMPI. o. 
All subjects passed all tests. 
The marijuana was obtained from the 
National Institute of Mental Health. t Two 
active grades containing 0.5% and 2.9% 
119 THC were used. The placebo material 
consisted of marijuana from which all of 
the 119 THC had been extracted without 
significant alteration of taste, . texture, and 
smell. In a small pilot experiment, the ex-
tracted material was given first under 
double-blind conditions. Experienced mari-
juana users had difficulty distinguishing 
the extracted marijuana from other ma-
terial they smoked. However, once they 
were given the most potent marijuana, no 
one had any difficulty identifying the ex-
tracted product at a later session. All sub-
jects smoked the marijuana cigarettes pre-
pared by the staff pharmacist at the 
Lafayette Clinic. The study was approved 
by the Human Use Committees of both the 
Lafayette Clinic and the University of 
Michigan. 
Initial experimental session. Eighteen 
subjects participated in an initial experi-
mental session in which individual dosage 
level was determined. During this session 
the subject was asked to smoke as much 
2.9% 11{l THC marijuana as he could to 
a maximum of 8 300 mg cigarettes. The 
subjects were aware of the quality of 
"Minnesota Multiphasic Personality Inventory. 
tSupplied by Dr. Monique Braude, Center for Studies 
of Narcotic and Drug Abuse, National Institute of Mental 
Health, Rockville, Md. 20852. 
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marijuana and were encouraged to con-
tinue smoking uritil they actually refused 
to smoke any more. Generally, the user 
decided to stop smoking because he was 
"too high" in spite of vigorous urging on 
the part of the experimenters. Both the 
subject and the experimenters knew prior 
to the beginning of this session that active 
marijuana was used. However, the users 
did not know the precise concentration of 
~!J THC in the cigarettes (2.9%). They 
were told that in this session it was im-
portant to establish the total dose level 
of marijuana that they would take and 
that in subsequent sessions the total 
amount smoked in this initial experimental 
session would be given. The subjects sub-
sequently returned to the laboratory for 
2 or 3 visits, a week or more later, and 
were given the same amounts of extracted 
marijuana. Twelve subjects were given 
0.5% 11" THC marijuana under the same 
circumstances with similar instructions. 
They received a similar number of ciga-
rettes. The variable number of subjects for 
each test is due to the fact that, for a 
variety of reasons, all did not participate. 
Physiological parameters were measured 
before and at various times after smoking. 
Each subject was asked to smoke as rapid-
ly as he could. Great care was taken to 
ensure that all would inhale deeply and 
retain the smoke in the accepted social 
manner. Subjects exhaling large amounts 
of smoke were instructed to inhale properly 
to ensure maximal absorption of the pyrol-
ysis products. Heart rate (Lead II) was 
recorded on a Grass polygraph. Blood pres-
sure from the dominant arm was obtained 
by auscultation using a mercury manom-
eter. Pupils were measured from a Polaroid 
color print under standard lighting condi-
tions with the subject looking at a fixed 
point approximately 5 feet away. A Pola-
roid CU -5 camera was used with a lens 
adapter. The patellar reflex was recorded 
automatically on the polygraph as was 
the electromyogram (EMG) of the quadri-
ceps femoris muscle. The patellar reflex 
was elicited with a mechanical rubber-
tipped hammer every 2 seconds. The iso-
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Table I. Effects of smoking mari;uana cigarettes of varying 6..9 THC content on 
Clyde Mood test scores in normal human volunteers 
a9 THe content 
0% I 0.5% 2.9% 
-----1 Mood Before I After Before After Before After 
Friendly 
Mean 50.0 48.0 51.0 55.0 55.0 53.0 
S.E. 1.8 3.4 3.3 1.7 8.9 13.0 
Aggressive 
Mean 51.0 49.0 48.0 49.0 52.0 52.0 
S.E. 2.3 0.9 2.2 1.9 1.9 2.1 
Clear-thinking 
Mean 51.0 47.0 48.0 45.0 50.0 44.0" 
S.E. 2.4 1.5 1.8 2.9 1.9 2.1 
Sleepy 
Mean 50.0 52.0 56.0 54.0 50.0 48.0 
S.E. 2.5 2.3 2.8 1.7 1.9 2.9 
Unhappy 
Mean 39.0 39.0 41.0 41.0 41.0 44.0 
S.E. 1.5 2.3 2.3 2.5 1.2 1.8 
Dizzy 
Mean 48.0 50.0 47.0 45.0 47.0 54.0" 
S.E. 0.9 1.8 1.8 1.5 1.2 3.1 
In this and all subsequent tables a paired comparison Student t test was used to determine the p value. 
Scores are expressed as mean number of points on a 0 to 4 scale for each adjective . 
• p < 0.05; a total of 9 subjects smoked 0%, 10 smoked 0.5%, and 18 smoked 2.9% /19 THe marijuana. 
metric muscle contraction was recorded 
simultaneously with a Grass FT 10 strain 
gauge. The apparatus is similar to that 
used previously' in tobacco smoking ex-
periments. Subjects were also asked to 
score themselves on a subjective 0 to 10 
scale with 10 as the maximal "high" they 
had in their lives. In addition, they took 
the Clyde Mood scale. 3 This entire se-
quence of measurements was done before 
and at approximately 15 minute intervals 
throughout the entire experiment, which 
lasted about 2 to 3 hours. 
Amount of marijuana smoked. A total 
of 18 subjects were given 2.9% 6..9 THC 
marijuana during the initial experimental 
session to determine the pOint of refusal. A 
total of eight 300 mg cigarettes was offered. 
Actually, no subject smoked more than 4 
of them. The reasons given for refusing 
additional marijuana were complex, but 
most subjects simply said that they were as 
"high" as they felt comfortable and did not 
wish to get "higher." On a 0 to 10 scale 
of which 0 was no "high" and 10 was the 
maximal "high" they had ever had in their 
lives, most subjects reported a "high" of 
10 or more. Only 2 subjects said they had 
ever had stronger marijuana in their lives. 
The mean subjective "high" ± S.E. for all 
subjects was 9.8 ± 0.5. The amount of 
marijuana each subject smoked varied 
Widely, ranging from 1 to a maximum of 
4 cigarettes. The mean (± S.E.) of the 
total amount of marijuana smoked was 
673.8 (± 61.7) mg. This multiplied by 2.9% 
gives a mean 6..9 THC of 19.5 (± 1.8) mg 
total. Assuming that 50% of the material 
was destroyed during smoking, this would 
mean that the subjects received an average 
total of 9.8 mg. This amount is consistent 
with other literature reports9- 11 of the 
amount of 6..9 THC taken either by inhala-
tion or orally that would give a rather 
marked subjective effect. Subjects smoked 
the marijuana cigarettes over a period of 
approximately 15 to 30 minutes. It was very 
difficult to have every subject smoke at a 
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Table II. Effects of smoking marijuana cigarettes of varying .609 THC content 
on palpebral fissure in normal human volunteers 
Mean palpebral fissure 
~9 THC ± S.E. ~ Palpebral 
content (%) N Before After fissure p Value 
0 8 8.7 ± 0.5 9.6 ± 0.8 + 0.9 > 0.05 
0.5 9 10.0 ± 0.7 9.5 ± 0.6 - 0.5 > 0.4 
2.9 9 9.3 ± 0.7 6.3 ± 0.8 - 3.0 < 0.001 
Units are in mm. 
Table III. Effects of smoking marijuana cigarettes of varying .609 THC content 
on pupil size in normal human volunteers 
~9 THC 
content (%) 
Mean pupil size ± S.E. 
N Before After ~ Pupil size p Value 
o 
0.5 
2.9 
8 
9 
8 
5.5 ± 0.1 5.2 ± 0.2 - 0.3 
0.0 
- 0.7 
> 0.2 
> 0.0 
< 0.02 
6.2 ± 0.3 6.2 ± 0.3 
6.1 ± 0.2 5.4 ± 0.2 
Units are in mm. 
more rapid pace. Most of these subjects 
reported that the brand of marijuana they 
smoked (unknown to them it was 2.9% 
D." THC marijuana) was among the best 
marijuana that they ever had. Only 2 
commented that they had previously re-
ceived such an "excellent" grade of mari-
juana. Most of the subjects thoroughly 
enjoyed their "high" and were in good 
spirits throughout the experiment, but 2 
subjects exhibited panic reactions and a 
third became stuporous and semicomatose. 
In fact, this subject, who took 30.2 mg total 
of .6oH THC, was so stuporous that he had to 
be placed in bed. When aroused he had 
periodic tremors and a transient rigidity. 
The neurological picture was identical to 
one previously seen in monkeys given the 
synthetic THC derivative DMHP. "'6, 8 About 
6 hours later this subject was able to get 
up and walk but he was still quite dis-
oriented. Interestingly, another individual 
who had much more experience with mari-
juana took 31.0 mg total of .609 THC and 
showed no stuporous reaction. Although 
he was quite "high," he could playa guitar 
very well. Both subjects were observed to 
o I-Hydroxy-3 ( 1,2-dimethylheptyl) -6,6,9-trimethyl 
7,8,9,lO-tetrahydro-6-dibenzopyran. 
inhale their marijuana equally well so that 
this represents either extremes in indi-
vidual differences or tolerance in the more 
frequent marijuana user. 
Effects on mood. The Clyde Mood test 
was given before and immediately after 
smoking marijuana. Difference scores were 
then calculated. The categories friendly, 
aggressive, clear-thinking, sleepy, unhappy, 
and dizzy were then analyzed for effects 
of 0, 0.5%, and 2.9% .609 THC-containing 
marijuana. As can be seen in Table I, 2.9% 
D." THC caused a decrease in clear think-
ing (p < 0.05) and an increase in dizzi-
ness (p < 0.02). No other significant 
changes were observed. These findings are 
consistent with what was grossly apparent 
during the marijuana high. Subjects had 
difficulty concentrating, with short-term 
memory loss. The latter was indicated by 
poor performance on serial 7's. In addi-
tion, the subjects frequently wished to lie 
down because of mild dizziness. 
Effects on the angle of the palpebral 
fissure and pupil size. Increasing doses of 
marijuana caused subjects to look and act 
"stoned." This was manifested by drooping 
eyelids. As can be seen in Table II, 2.9% 
.60 9 THC marijuana causes a narrowing of 
the palpebral fissure (p < 0.001). This 
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Table IV. Effects of smoking marijuana cigarettes of varying 6.9 THC content 
on patellar reflex in normal human volunteers 
Mean amplitude:': S.E. 
fl9 THC in % of original fl Patellar 
content (%) N Before I After reflex in % p Value 
0.0 8 100 :': 0 137 :': 25 37 > 0.1 
0.5 8 100 :': 0 233 ± 39 133 = 0.01 
2.9 7 100 :': 0 236 :': 74 136 > 0.1 
Table V. Effects of smoking marijuana cigarettes of varying 6.9 THC content 
on heart rate in normal human volunteers 
fl9 THC Mean heart rate:': S.E. 
content (%) N Before 
0.0 12 71 :': 1.3 
0.5 10 81 :': 2.6 
2.9 18 71 :': 2.4 
Units are in beats per minute. 
apparently contributes to their "stoned" 
look. A surprising finding was that there 
was a very small but consistent decrease 
in pupil size after smoking 2.9% 6.9 THC, 
which was not evident upon gross inspec-
tion but was significant by pupillography 
(p < 0.02). (Table III). 
Effects on the patellar reflex. In contrast 
to smoking extracted marijuana (0% 6.9 
TMC) cigarettes in which a slight in-
crease in patellar reflex was observed, 0.5% 
and 2.9% 6.9 THC marijuana caused a 
marked facilitation of the patellar reflex, 
approximately 133% to 136% increase. 
Strangely, this effect plateaued at the lower 
dose of 6.9 THC and there was no further 
enhancement of the patellar reflex with 
2.9% 6.9 THC marijuana. In fact, with the 
larger dose of marijuana there was marked 
variability between subjects in which some 
showed a marked increase and others no 
change or even decrease. The facilitating 
effect on the patellar reflex was most con-
sistent (p < 0.01) with the low dose of 
6.9 THC marijuana (Table IV). 
Cardiovascular effects of marijuana. As 
has been reported by several groups,12, 13 
smoking marijuana produces dose-related 
increase in heart rate. This finding was 
After fl Heart rate p Value 
73 :': 1.9 + 2 > 0.1 
96 :': 3.2 + 15 < 0.01 
128 :': 5.7 + 57 < 0.001 
reconfirmed by data summarized in Table 
V. It can be seen that 0.5% 6.9 THC pro-
duced a 15 beat per minute increase over 
control levels (p < 0.01), while smoking 
2.9% 6.9 THC-containing marijuana caused 
an increase of 57 beats per minute over 
control levels (p < 0.001). In contrast, 
0% 6.9 THC marijuana caused no signifi-
cant change in heart rate. 
Although 0% and 0.5% 6.9 THC mari-
juana caused no significant change in blood 
pressure, 2.9% 6.9 THC marijuana caused a 
slight but significant (p < 0.01) increase 
in both systolic and diastolic blood pres-
sure (Table VI). 
Discussion 
The present study confirms and extends 
previous findings in the literature con-
cerning the clinical, pharmacological, and 
behavioral effects of marijuana smoking in 
young adult volunteers. In general, no sub-
ject voluntarily smoked more than four 300 
mg 2.9% Llf) THC-containing cigarettes. 
No subjects testing this concentration of 
boD THC took more than 31 mg. This dose 
is calculated on the assumption that there 
was a steady 50% delivery of bo9 THC 
throughout the smoking session, which is 
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Table VI. Effects of smoking mariiuana cigarettes of varying ~9 THe content 
on systolic and diastolic blood pressure in normal human volunteers 
/19 THe Systolic blood pressure Diastolic blood pressure 
content Mean ± S.E. Mean ± S.E. 
(%) N Before After 
1/1 Blood I 
pressure p Value Before After 
1/1 Blood I 
pressure p Value 
0.0 8 120 ± 1.0 122 ± 1.3 + 2 
0.5 10 122 ± 1.9 122 ± 4.0 0 
2.9 14 123 ± 2.5 138 ± 4.9 + 15 
Units are in mm Hg. 
by no means certain. This is a relatively 
large amount by inhalation compared to 
the usual doses of ~" THe given by mouth 
in most studies. 
It should be emphasized that our sub-
jects did not know that they were smoking 
the strongest marijuana available to us. 
They were urged repeatedly by the ex-
perimenter to smoke more cigarettes to a 
maximum of 8. Why did they stop when 
they actually anticipated taking all that 
was offered of "government grass?" The 
findings of Isbell and associatesll that 50 
J-tg per kilogram of ~9 THe injected into 
a tobacco cigarette produced in their sub-
jects a "social high" while 250 J-tg per 
kilogram was "hallucinogenic" may provide 
a partial answer. If one takes 80 kg as the 
mean weight of our subjects, that is (0.05 
x 80) 4.0 mg total of ~ 9 THC for a "social 
high" dose; a hallucinogenic dose would 
be 20 mg (0.25 x 80) total ~" THC by 
inhalation. Many of our subjects easily 
achieved and possibly exceeded this dose 
of ~" THe. The incidence of hallucinations 
was much lower than reported by Isbell 
and associates.l1 The role of nicotine-con-
taining tobacco spiked with ~9 THC in 
their study is unknown, but one would not 
expect a higher incidence of hallucinations. 
Inasmuch as many of our subjects were 
frequent marijuana users, one would sus-
pect that tolerance is a factor (as observed 
in animals" "' l~ ). In any event, one is 
forced to conclude that in large amounts 
~9 THe becomes more dysphoric and 
hence less reinforcing. Our subjects did 
not wish to go beyond the psychological 
and physical states they were in. The rea-
> 0.1 78 ± 2.0 79 ± 2.4 + 1 > 0.05 
> 0.9 76 ± 1.4 79 ± 2.2 + 3 > 0.05 
< 0,01 81 ± 1.4 89 ± 2.1 + 8 = 0.01 
sons given were vague but the fact was 
clear. 
The pharmacological changes observed 
in the present study are consistent with 
some reported in the literature. The sub-
jective mood changes of less clear thinking 
and dizziness would be expected of the 
larger doses of marijuana. The finding of 
a narrowed palpebral fissure further sup-
ports our previous report." The slight con-
striction of the pupils after marijuana as 
measured by pupillography was unex-
pected but is consistent with the lack of 
gross pupillary changes observed clinically. 
The dose-related increase in heart rate 
following marijuana smoking as well as 
~9 THe administration to man has now 
been observed by many. The slight in-
crease in the patellar reflex and arterial 
blood pressure after marijuana smoking 
was unexpected but a significant finding 
compared to THe extracted marijuana. 
Recently Cappell, Kuchar, and Webster2 
have offered evidence that psychosocial 
variables may be more significant than 
pharmacological variables in determining 
the "recreational" intake of marijuana. 
The fact that our subjects given 0.5% ~9 
THe marijuana tended to limit themselves 
to 4 cigarettes also supports this hypothe-
sis. However, the pharmacological effects 
of the lower dose of ~9 THe were much 
less obvious compared to the 2.9% ~9 THC 
material. 
The present study indicates the im-
portance of dose effect in marijuana smok-
ing. Depending on the amount smoked, 
several different conclusions could be 
drawn. No serious side effects were ob-
520 Domino, Rennick, and Pearl 
served with the lower ~!l THe-containing 
marijuana cigarettes other than the usual 
mild reversible organic brain syndrome 
previously reported2:J and the tachycardia. 
It should be noted that occasional subjects 
have been observed to show electrocardio-
gram (EKG ) abnormalities, including 
premature ventricular contractions.12,14 
Except, of course, for the tachycardia, most 
of our subjects showed only slight EKG 
changes. 
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